Highlights and Quick Summary
- Repayment/Issuance of Debt (Net) for the quarter ending December 31, 2020 was $-10 Million (a -Infinity% decrease compared to previous quarter)
- Year-over-year quarterly Repayment/Issuance of Debt (Net) decreased by -200.64%
- Annual Repayment/Issuance of Debt (Net) for 2020 was $-64 Thousand
- Twelve month Repayment/Issuance of Debt (Net) ending December 31, 2020 was $-64 Thousand (a -100.64% decrease compared to previous quarter)
Trailing Repayment/Issuance of Debt (Net) for the last four month:
| 31 Dec '20 | 30 Sep '20 | — | — |
|---|---|---|---|
| $-64 Thousand | $9.94 Million | — | — |
Visit stockrow.com/DYN
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Repayment/Issuance of Debt (Net) of Dyne Therapeutics, Inc.
Most recent Repayment/Issuance of Debt (Net)of DYN including historical data for past 10 years.Interactive Chart of Repayment/Issuance of Debt (Net) of Dyne Therapeutics, Inc.
Dyne Therapeutics, Inc. Repayment/Issuance of Debt (Net) for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2020 | $-10.0 | $0.0 | $0.0 | $9.94 | $-0.06 |
| 2019 | $0.0 | – | – | – | – |
Business Profile of Dyne Therapeutics, Inc.
Sector: Healthcare
Industry: Biotechnology